Glucocorticoids and non-alcoholic fatty liver disease
- 1 November 2015
- journal article
- review article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 154, 94-103
- https://doi.org/10.1016/j.jsbmb.2015.07.020
Abstract
No abstract availableKeywords
This publication has 112 references indexed in Scilit:
- Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer developmentMolecular and Cellular Endocrinology, 2012
- Regulation of triglyceride metabolism by glucocorticoid receptorCell & Bioscience, 2012
- Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolismJournal of Lipid Research, 2011
- DNA binding-dependent glucocorticoid receptor activity promotes adipogenesis via Krüppel-like factor 15 gene expressionLaboratory Investigation, 2011
- LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in miceJCI Insight, 2011
- Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver diseaseBioFactors, 2010
- Pathogenesis of non-alcoholic fatty liver diseaseQJM: An International Journal of Medicine, 2009
- Angiopoietin-like 4 (ANGPTL4, Fasting-induced Adipose Factor) Is a Direct Glucocorticoid Receptor Target and Participates in Glucocorticoid-regulated Triglyceride MetabolismOnline Journal of Public Health Informatics, 2009
- Glucocorticoid receptor haploinsufficiency causes hypertension and attenuates hypothalamic‐pituitary‐adrenal axis and blood pressure adaptions to high‐fat dietThe FASEB Journal, 2008
- Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis*Journal of Lipid Research, 2008